Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis After Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation

PTCy-based GVHD prophylaxis after MMUD HSCT with PBSC grafts results in favorable 1 year OS. Using MMUDs expands donor availability to all patients regardless of ancestry (ACCESS; ClinicalTrials.gov identifier: NCT04904588).

Authors

Institutions

Publication Details

Journal
Journal of Clinical Oncology
Published
2025-06-16
DOI
https://doi.org/10.1200/jco-25-00856
Citations
12
Primary Topic
Hematopoietic Stem Cell Transplantation
Type
article
Field-Weighted Citation Impact
21.24
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis After Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation

Steven M. Devine, Rachel Cusatis, Mehdi Hamadani, Antonio Jiménez et al.
12 citations
Journal of Clinical Oncology
Hematopoietic Stem Cell Transplantation
21.24
article

Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis After Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation

Steven M. Devine, Rachel Cusatis, Mehdi Hamadani, Antonio Jiménez, Farhad Khimani, Brent R. Logan, Medhat Askar, Bronwen E. Shaw, Muna Qayed, Martin Maiers, Sally Arai, Erin Leckrone, Alison W. Loren, Mahasweta Gooptu, Stephanie Bo‐Subait, Karen K. Ballen, Monzr M. Al Malki, Heather E. Stefanski, Sung Won Choi, Sarah Smith, Brian C. Shaffer, Stephen R. Spellman, Jianqun Kou, Stephanie Fingerson, Rachel J. Cook, Abeer Madbouly, Jeffery J. Auletta, Dipenkumar Modi, Larisa Broglie, Karilyn Larkin, Juan Wu, Craig Malmberg, Janelle A. Olson
article en
12 citations

Abstract

PTCy-based GVHD prophylaxis after MMUD HSCT with PBSC grafts results in favorable 1 year OS. Using MMUDs expands donor availability to all patients regardless of ancestry (ACCESS; ClinicalTrials.gov identifier: NCT04904588).

Journal of Clinical OncologyVol. 43(25)
City Of Hope National Medical Center (US), National Marrow Donor Program (US), Memorial Sloan Kettering Cancer Center (US), University of Miami (US), Emory University (US), Oregon Health & Science University (US), Wayne State University (US), Medical College of Wisconsin (US), University of Michigan (US), Moffitt Cancer Center (US), The Barbara Ann Karmanos Cancer Institute (US), Stanford Health Care (US), Dana-Farber Cancer Institute (US), Children's Healthcare of Atlanta (US), University of Virginia (US), The Ohio State University (US), Qatar University (QA), University of Pennsylvania (US)
Good health and well-being
Openalex Percentile: Top 0%
Hematopoietic Stem Cell Transplantation
21.24
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.